Page last updated: 2024-08-24

oseltamivir and g(m1) ganglioside

oseltamivir has been researched along with g(m1) ganglioside in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crain, SM; Shen, KF1
Chi, MH; Goleniewska, K; Higginbotham, JN; Moore, ML; O'Neal, JF; Peebles, RS; Zhou, W1

Other Studies

2 other study(ies) available for oseltamivir and g(m1) ganglioside

ArticleYear
Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice.
    Brain research, 2004, Jan-09, Volume: 995, Issue:2

    Topics: Acetamides; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; G(M1) Ganglioside; Hyperalgesia; Male; Mice; Morphine; Neuraminidase; Neurons; Oseltamivir; Pain Measurement; Receptors, Opioid; Time Factors

2004
Cutting Edge: Oseltamivir decreases T cell GM1 expression and inhibits clearance of respiratory syncytial virus: potential role of endogenous sialidase in antiviral immunity.
    Journal of immunology (Baltimore, Md. : 1950), 2007, Mar-01, Volume: 178, Issue:5

    Topics: Animals; Antiviral Agents; CD8-Positive T-Lymphocytes; Down-Regulation; Female; G(M1) Ganglioside; Immunity, Cellular; Lymphocyte Activation; Membrane Microdomains; Mice; Mice, Inbred BALB C; Neuraminidase; Oseltamivir; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Signal Transduction

2007